MGIA
PBLA

Moneta Group Investment Advisors’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Moneta Group Investment Advisors’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20
Closed -$5.31K – 588
2023
Q1 		$5.31K Buy
+20
New +$19.4K ﹤0.01% 538

Other funds holding PBLA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Moneta Group Investment Advisors's PBLA Position: Q2 2023 in Review

Moneta Group Investment Advisors sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q2 2023, closing a stake of 20 shares — an estimated $5.31K sold.

Moneta Group Investment Advisors first reported a position in PBLA in Q1 2023 and held it in 1 quarter. The position peaked at $5.31K in Q1 2023. 6 funds tracked by Wall St. Rank hold PBLA as of Q2 2023.

  • Moneta Group Investment Advisors reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 20 Panbela Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $5.31K.
  • Moneta Group Investment Advisors first reported a position in Panbela Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Moneta Group Investment Advisors's Panbela Therapeutics, Inc. Common Stock position peaked at $5.31K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.